Outreach activities

The need to study chromosome stability

Advances in medicine have enabled people to work more efficiently and live longer. However, this advance has also been associated with an increase in the incidence of cancer, age-related neurological abnormalities and impaired fertility due to a delay in birth age in women. Many of these disorders are caused by changes in the blueprint (DNA) of cells in our body after we are born. The DNA in our cells is organized into chromosomes, and therefore it is important for us to decipher the stability of the chromosomes in the different type of cells in our body.

A concerted effort in knowledge sharing in the CCS

In the CCS, we have seven research groups studying the stability of chromosomes from different angles using different tools and models. These groups have close collaborations with each other through sharing research facilities, attending joint research-in-progress meetings, and having center and departmental retreats. Moreover, the CCS group leaders have multiple collaborations with research groups in Denmark or abroad, so that they can always be at the forefront of this research field nationally and internationally. In addition to the funding we received from DNRF, we have also been successful in applying for external funding agencies (including private funds and European grants) to support our research. This allows us not only to conduct the most advanced research, but also to distribute our research ideas to potential industry collaborators. Furthermore, the research in the CCS is widely disseminated to the scientific community via publications or presentations in international journals, books, conferences, or teaching classes.

Public outreach activities

One of the missions of CCS is to increase public awareness of the importance of the maintenance of chromosome stability in our cells, and to understand the nature of our research. CCS group leaders will describe their research focus and goals in videos posted on YouTube on the regular basis. We also engage in direct dialogue with clinicians and patients, and will post our progress or commentaries on social media including Facebook and Twitter.